← All trials

NCT90000003

Phase 2Interventional

Phase 2

View on ClinicalTrials.gov ↗

Timeline

Start date
Jun 1, 2017
Primary completion
Dec 1, 2018
Completion date
Jan 1, 2019
First posted
May 1, 2017
Last posted
Feb 1, 2019
Enrollment
120
Arms / groups
3 / 3
Source
ClinicalTrials.gov · AACT

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.